randomized comparison oxytocin sulprostone placebo management third stage labour OBJECTIVE effect post partum bloodloss postpartum prophylactic administration oxytocin sulprostone low risk women expectant management third stage DESIGN Randomized placebo double-blind trial SETTING Radboud University Hospital Nijmegen women Lievensberg Hospital Bergen op Zoom women PARTICIPANTS women trial INTERVENTIONS intramuscular injection birth baby oxytocin IU micrograms saline MAIN OUTCOME MEASURES Quantitative postpartum blood loss length third stage RESULTS Postpartum blood loss oxytocin sulprostone mean length third stage groups active treatment effect significant sulprostone group CONCLUSION Prophylactic administration oxytocin sulprostone delivery expectant management third stage reduces partum blood loss third stage 